Leading data on the treatment of in-stent restenosis with pantheris presented at charing cross international symposium

Redwood city, ca / accesswire / april 28, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced the presentation of clinical data from the insight study during the charing cross (cx) international symposium in london, england. the cx symposium is a leading vascular and endovascular education conference focused on education, innovation, and evidence.
AVGR Ratings Summary
AVGR Quant Ranking